Long-Term Assessment of Safety and Physical Function With AMG 108 in RA

Status:
Completed

Trial end date:
2008-06-01

Target enrollment:

Participant gender:

The purpose of this study is to assess long-term safety of SC AMG 108 in the treatment of RA

Phase 2

Amgen

Antibodies, Monoclonal